Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Follicular Lymphomas with and without Translocation t(14;18) Differ in Gene Expression Profiles and Genetic Alterations.

Ellen Leich, Itziar Salaverria, Silvia Bea, PhD, Andreas Zettl, MD, Randy D. Gascoyne, MD, Wing-Chung Chan, MD, Rita M. Braziel, MD, Lisa M. Rimsza, MD, Dennis D. Weisenburger, MD, Jan Delabie, MD, Elaine S. Jaffe, MD, Thomas A. Lister, Andrew J. Norton, MD, Louis M. Staudt, MD, PhD, Elena M. Hartmann, MD, Hans-Konrad Mueller-Hermelink, MD, Elias Campo, MD, PhD, German Ott, MD, Andreas Rosenwald, MD

Blood (2007) 110 (11): 360.

https://doi.org/10.1182/blood.V110.11.360.360

Published: 2007

Journal Articles

Angiogenesis Assessed in Tissue Microarrays of Diagnostic Follicular Lymphoma Correlates with Outcome.

Andrew J. Clear, BSc (Hons), Abigail M. Lee, MBBS, Kelly J. Morris, BSc(Hons), Maria Calaminici, MD, PhD, Finlay Macdougall, BA, Rodrigo Proto-Siqueira, PhD, Lindsey K. Goff, PhD, Thomas A. Lister, MD, John G. Gribben, MD DSc

Blood (2007) 110 (11): 2609.

https://doi.org/10.1182/blood.V110.11.2609.2609

Published: 2007

Journal Articles

Phase I Trial of the 131 I-Labelled Anti-CD25 Antibody Basiliximab in the Treatment of Patients with Relapsed or Refractory Lymphoma.

Gairin Dancey, MB, BS, John Violet, PhD, Shokri Othman, BSc, Sweta Parker, MSc, Alan Green, PhD, Surinder Sharma, PhD, Ros Francis, PhD, Natalie Griffin, BSc, Pei-San Chan, BSc, MRPharmS, Peter Amlot, MD, Anmol Malhotra, FRCR, Nicholas Woodward, FRCR, Peter Isaacson, FRCP, Thomas A. Lister, PhD, John Buscombe, MD, Richard Begent, MD, Christopher McNamara, MB, BS

Blood (2007) 110 (11): 648.

https://doi.org/10.1182/blood.V110.11.648.648

Published: 2007

Journal Articles

Enteropathy-Type T-Cell Lymphoma: Clinical Features of a Series of 62 Cases. Jan Delabie, Harald Holte, Andrew Lister and Julie Vose for the International T-Cell Lymphoma Project.

Jan Delabie, MD, Harald Holte, MD, Thomas A. Lister, MD, Julie M. Vose, MD

Blood (2006) 108 (11): 2459.

https://doi.org/10.1182/blood.V108.11.2459.2459

Published: 2006

Journal Articles

The Activity of the Novel Aurora Kinase B Inhibitor AZD1152 in Acute Myeloid Leukaemia Cells.

Simon P. Joel, PhD, Adedayo Oke, PhD, Nichola Foot, BSc, Nick Keen, PhD, Dominique Bonnet, PhD, Thomas A. Lister, MD, Jude Fitzgibbon, PhD

Blood (2005) 106 (11): 3374.

https://doi.org/10.1182/blood.V106.11.3374.3374

Published: 2005

Journal Articles

The Follicular Lymphoma International Prognostic Index (FLIPI) Can Be a Useful Prognostic Indicator for Patients with Follicular Lymphoma Treated with Combination of Rituximab and Epratuzumab.

Sandra J. Strauss, MD, Franck Morschhauser, MD, Martin Gramatzki, MD, Philippe Solal-Celigny, MD, PhD, Pier L. Zinzani, MD, Andreas Engert, MD, Bertrand Coiffier, MD, Dieter Hoelzer, MD, PhD, Nick Teoh, PhD, William A. Wegener, MD, PhD, David M. Goldenberg, ScD, MD, Ivan D. Horak, MD, Thomas A. Lister, MD

Blood (2005) 106 (11): 4796.

https://doi.org/10.1182/blood.V106.11.4796.4796

Published: 2005

Journal Articles

Discrimination of Long and Short Survival in Follicular Lymphoma (FL) Patients by Incidence of FOXP3 and Perifollicular Incidence of CD4 and CD7 Using Immunohistochemistry on Tissue Microarray (TMA) of Diagnostic Lymph Nodes (LN).

Lindsey K. Goff, PhD, Abigail M. Lee, MBBS, Andrew Clear, BSc, Maria Calaminici, MD, PhD, Andrew J. Davies, MBBS, Suzanne Jordan, BSc, Finlay Macdougall, BA, Janet Matthews, BSc, Andrew J. Norton, MBBS, John G. Gribben, MD DSc, Thomas A. Lister, MD

Blood (2005) 106 (11): 603.

https://doi.org/10.1182/blood.V106.11.603.603

Published: 2005

Journal Articles

Follow-Up Results of a Prospective, Multicenter, Open-Label Study of Oral Fludarabine Phosphate in Patients with Previously Untreated B-CLL.

Jean-Francois Rossi, A. Van Hoof, K. De Boeck, S. A. Johnson, D. Bron, C. Foussard, T. A. Lister, M. H.H. Kramer, T. J. Littlewood, R. E. Marcus, E. Deconinck, O. Guibon, M. Montillo, S. M. Tollerfield

Blood (2005) 106 (11): 2128.

https://doi.org/10.1182/blood.V106.11.2128.2128

Published: 2005

Journal Articles

Flow Cytometric FLT3 Expression in Acute Leukaemias Is of Diagnostic Value but Does Not Correlate with ITD / D835Y Mutation Status.

Colin Ridler, Matthew Smith, Tim Milne, Fatema Ebrahim, Marion Macey, T. A. Lister, Jude Fitzgibbon, Jamie D. Cavenagh, Samir G. Agrawal

Blood (2004) 104 (11): 3014.

https://doi.org/10.1182/blood.V104.11.3014.3014

Published: 2004

Journal Articles

Lymphdx: A Custom Microarray for Molecular Diagnosis and Prognosis in Non-Hodgkin Lymphoma.

Blood (2004) 104 (11): 701.

https://doi.org/10.1182/blood.V104.11.701.701

Published: 2004

Journal Articles

Mantle Cell and Follicular Lymphoma Samples Demonstrate Differing Sensitivity to Bortezomib in a Primary Culture System.

Lenushka Maharaj, MSc, Sandra J. Strauss, MD, Jim Stec, Thomas A. Lister, Simon P. Joel, PhD

Blood (2004) 104 (11): 3294.

https://doi.org/10.1182/blood.V104.11.3294.3294

Published: 2004

Journal Articles

Rituximab (Anti-CD20 Monoclonal Antibody) for the Treatment of Patients With Relapsing or Refractory Aggressive Lymphoma: A Multicenter Phase II Study

B. Coiffier, C. Haioun, N. Ketterer, A. Engert, H. Tilly, D. Ma, P. Johnson, A. Lister, M. Feuring- Buske, J.A. Radford, R. Capdeville, V. Diehl, F. Reyes

Blood (1998) 92 (6): 1927–1932.

https://doi.org/10.1182/blood.V92.6.1927

Published: 1998

NARROW

Follicular Lymphomas with and without Translocation t(14;18) Differ in Gene Expression Profiles and Genetic Alterations.

Angiogenesis Assessed in Tissue Microarrays of Diagnostic Follicular Lymphoma Correlates with Outcome.

Phase I Trial of the 131 I-Labelled Anti-CD25 Antibody Basiliximab in the Treatment of Patients with Relapsed or Refractory Lymphoma.

Enteropathy-Type T-Cell Lymphoma: Clinical Features of a Series of 62 Cases. Jan Delabie, Harald Holte, Andrew Lister and Julie Vose for the International T-Cell Lymphoma Project.

The Activity of the Novel Aurora Kinase B Inhibitor AZD1152 in Acute Myeloid Leukaemia Cells.

The Follicular Lymphoma International Prognostic Index (FLIPI) Can Be a Useful Prognostic Indicator for Patients with Follicular Lymphoma Treated with Combination of Rituximab and Epratuzumab.

Discrimination of Long and Short Survival in Follicular Lymphoma (FL) Patients by Incidence of FOXP3 and Perifollicular Incidence of CD4 and CD7 Using Immunohistochemistry on Tissue Microarray (TMA) of Diagnostic Lymph Nodes (LN).

Follow-Up Results of a Prospective, Multicenter, Open-Label Study of Oral Fludarabine Phosphate in Patients with Previously Untreated B-CLL.

Flow Cytometric FLT3 Expression in Acute Leukaemias Is of Diagnostic Value but Does Not Correlate with ITD / D835Y Mutation Status.

Lymphdx: A Custom Microarray for Molecular Diagnosis and Prognosis in Non-Hodgkin Lymphoma.

Mantle Cell and Follicular Lymphoma Samples Demonstrate Differing Sensitivity to Bortezomib in a Primary Culture System.

Rituximab (Anti-CD20 Monoclonal Antibody) for the Treatment of Patients With Relapsing or Refractory Aggressive Lymphoma: A Multicenter Phase II Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only